Search

A targeted drug shows promise for controlling pleural mesothelioma.

… Monday, May 16, 2022 Mesothelioma is a rare, aggressive cancer affecting the lining that surrounds organs. The most common form of the disease, pleural mesothelioma, develops in the tissue lining the lungs. The disease is very difficult to treat because it does not grow as a solid tumor and is usually

… Tuesday, May 5, 2026 John Maciejowski Awarded Chairman’s Prize John Maciejowski, a fifth-year graduate student in Prasad Jallepalli’s lab in the Molecular Biology Program, was awarded the Chairman’s Prize for his first-author paper Mps1 directs the assembly of Cdc20-inhibitory complexes during interphase

An international study led by MSK researchers has found that, when used to treat large B cell lymphoma, CAR T immunotherapy may work better when given earlier in the day.

… Monday, January 5, 2026 When it comes to giving immunotherapy to people with the most common form of lymphoma, the time of day may make a difference, according to new research from Memorial Sloan Kettering Cancer Center (MSK). People who receive chimeric antigen receptor (CAR) T cell therapy in the morning

Fourth-year student Jeff Smith received a Breast Cancer Research Program Predoctoral Traineeship Award from the Department of Defense Congressionally Directed Medical Research Programs.

… Monday, March 15, 2010 Fourth-year student Jeff Smith received a Breast Cancer Research Program Predoctoral Traineeship Award from the Department of Defense Congressionally Directed Medical Research Programs. This award is made based on the recipient’s talent, potential, and commitment to breast cancer

The pandemic has raised important issues for clinicians, and, after weighing the risks and benefits, the Colorectal Disease Management Team at MSK decided that all patients with locally advanced colorectal cancer will be treated with short-course radiation therapy rather than standard long-course chemoradiation therapy.

… Monday, May 11, 2020 The COVID-19 pandemic is consuming a significant amount of healthcare resources, especially in New York City, which became the global epicenter of the outbreak at the end of March 2020. Given the concerns around rapidly rising infection rates, impending staffing shortages, and the

Breakthrough findings illustrate the promise of precision oncology and signify a paradigm shift in drug development. Interim data from three trials show a 76 percent confirmed overall response rate in patients treated with the TRK inhibitor.

… Saturday, June 3, 2017 Larotrectinib (LOXO-101) has demonstrated consistent and durable antitumor activity in tropomyosin receptor kinase (TRK) fusion cancers across a wide range of patient ages and tumor types and was well tolerated by patients, according to results from three clinical trials presented

A study from investigators in the Sloan Kettering Institute uncovers the details of how a key protein called GRP94 becomes disrupted, leading to cancer and other diseases.

… Tuesday, June 30, 2020 Summary A study from investigators in the Sloan Kettering Institute reveals how a protein called GRP94, which is normally a “good guy” in the cell, turns bad when it has a sugar molecule added to it. In molecular biology, chaperones are a class of proteins that help regulate how

Learn about the latest treatments for colon and rectal (colorectal) cancer at Memorial Sloan Kettering Cancer Center.

… Tuesday, January 13, 2026 Colorectal cancer , which includes cancer of both the  colon and the  rectum , is the third most common cancer in both men and women in the United States. There is encouraging news about the disease on many fronts. Overall, the incidence of colorectal cancer is decreasing, and

MSK colleagues pay tribute to molecular biologist Jerard Hurwitz’s scientific accomplishments and passion for discovery.

… Friday, February 1, 2019 Summary Former MSK researcher Jerard Hurwitz, who died last week, had an immeasurable impact on the field of molecular biology. Here, former colleagues recall his devotion to laboratory research and scientific rigor. Joan Massagué fondly recalls his first encounter with Jerard

In response to low national vaccination rates for the human papillomavirus (HPV), Memorial Sloan Kettering Cancer Center (MSK) has joined with the 68 other National Cancer Institute (NCI)–designated cancer centers in issuing a statement urging for increased HPV vaccination for the prevention of cancer. These institutions collectively recognize insufficient vaccination as a public health threat and call upon the nation’s physicians, parents, and young adults to take advantage of this rare opportunity to prevent many types of cancer.

… Wednesday, January 27, 2016 In response to low national vaccination rates for the human papillomavirus (HPV), Memorial Sloan Kettering Cancer Center (MSK) has joined with the 68 other National Cancer Institute (NCI)–designated cancer centers in issuing a statement urging for increased HPV vaccination